MX2012008253A - Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida. - Google Patents

Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida.

Info

Publication number
MX2012008253A
MX2012008253A MX2012008253A MX2012008253A MX2012008253A MX 2012008253 A MX2012008253 A MX 2012008253A MX 2012008253 A MX2012008253 A MX 2012008253A MX 2012008253 A MX2012008253 A MX 2012008253A MX 2012008253 A MX2012008253 A MX 2012008253A
Authority
MX
Mexico
Prior art keywords
pharmaceutical use
aids agents
multicyclic compounds
multicyclic
aids
Prior art date
Application number
MX2012008253A
Other languages
English (en)
Inventor
Luiz Francisco Pianowski
Joao Batista Calixto
Claudio Paulino Chaves
Original Assignee
Amazonia Fitomedicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amazonia Fitomedicamentos Ltda filed Critical Amazonia Fitomedicamentos Ltda
Publication of MX2012008253A publication Critical patent/MX2012008253A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La invención se refiere al uso farmacéutico de compuestos multicíclicos seleccionados de ingenoles, Ianosta-8,24-dien-3-oles y sus mezclas, como agentes anti-SIDA.
MX2012008253A 2010-01-15 2010-01-15 Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida. MX2012008253A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2010/050198 WO2011086423A1 (en) 2010-01-15 2010-01-15 Pharmaceutical use of multicyclic compounds as anti-aids agents

Publications (1)

Publication Number Publication Date
MX2012008253A true MX2012008253A (es) 2012-08-15

Family

ID=42735537

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008253A MX2012008253A (es) 2010-01-15 2010-01-15 Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida.

Country Status (13)

Country Link
US (1) US20120289487A1 (es)
EP (1) EP2523663A1 (es)
JP (1) JP2013517262A (es)
KR (1) KR20120112707A (es)
CN (1) CN102711750A (es)
AU (1) AU2010342326A1 (es)
BR (1) BR112012017211A2 (es)
CA (1) CA2787236A1 (es)
CR (1) CR20120395A (es)
MX (1) MX2012008253A (es)
RU (1) RU2012134786A (es)
SG (1) SG182413A1 (es)
WO (1) WO2011086423A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013225633B2 (en) * 2012-03-02 2017-11-23 Amazonia Fitomedicamentos Ltda. Ingenol derivatives in the reactivation of latent HIV
CN108524448B (zh) * 2017-03-02 2019-10-18 新疆维吾尔自治区药物研究所 一种大戟二烯醇抗白内障眼用制剂及其制备方法和用途
CN109021051A (zh) * 2017-06-12 2018-12-18 盛世泰科生物医药技术(苏州)有限公司 四环三萜类化合物的晶型及其用途
CN109912419A (zh) * 2017-12-13 2019-06-21 复旦大学 巨大戟烷型二萜及其在制备抗艾滋病毒药物中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006007676A1 (en) * 2004-07-21 2006-01-26 Amazônia Fitomedicamentos Ltda. Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
ES2428244T3 (es) 2005-06-28 2013-11-06 Amaz�Nia Fitomedicamentos Ltda. Fracci�n activa de un extracto de disolvente polar del l�tex de plantas Euforbi�ceas

Also Published As

Publication number Publication date
CN102711750A (zh) 2012-10-03
US20120289487A1 (en) 2012-11-15
AU2010342326A1 (en) 2012-08-09
BR112012017211A2 (pt) 2019-09-24
WO2011086423A1 (en) 2011-07-21
CR20120395A (es) 2012-08-30
KR20120112707A (ko) 2012-10-11
EP2523663A1 (en) 2012-11-21
JP2013517262A (ja) 2013-05-16
CA2787236A1 (en) 2011-07-21
SG182413A1 (en) 2012-08-30
RU2012134786A (ru) 2014-02-20

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
UY33735A (es) Compuestos antivirales
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
PH12014502697B1 (en) New diazaspirocycloalkane and azaspirocycloalkane
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
IN2015DN03029A (es)
GEP201706710B (en) Imidazopyridazine derivatives as gabaa receptor modulators
JO3154B1 (ar) عوامل مضادة لـ trpv4
EA201101194A1 (ru) Применение розувастатин лактолов в качестве лекарственных препаратов
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
MX2012008253A (es) Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida.
MY165088A (en) Pharmaceutical compositions comprising alisporivir
IN2015DN02643A (es)
IN2015DN02645A (es)
IN2013MU03317A (es)
MX354501B (es) Ingrediente perfumante de la familia galbano.
WO2012004073A3 (de) Verwendung von beta-isophoron als lösemittel
MA33932B1 (fr) Dérivés de 2-aldoximino-5-fluoropyrimidine
IN2015DN02647A (es)
IN2015DN02646A (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal